Ignite Creation Date:
2025-12-24 @ 11:50 AM
Ignite Modification Date:
2026-01-06 @ 1:19 PM
Study NCT ID:
NCT00136461
Status:
COMPLETED
Last Update Posted:
2011-03-10
First Post:
2005-08-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of All-Trans Retinoic Acid (ATRA) and Bryostatin in Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
Sponsor:
Dana-Farber Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
1997-05
Start Date Type:
None
Primary Completion Date:
2000-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2000-08
Completion Date Type:
ACTUAL
First Submit Date:
2005-08-25
First Submit QC Date:
None
Study First Post Date:
2005-08-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-03-09
Last Update Post Date:
2011-03-10
Last Update Post Date Type:
ESTIMATED